CDXS
Codexis, Inc. Healthcare - Biotechnology Investor Relations →
Codexis, Inc. (CDXS) closed at $1.33 as of 2026-02-02, trading 67.0% below its 200-week moving average of $4.04. This places CDXS in the extreme value zone. The stock moved further from the line this week, up from -70.0% last week. With a 14-week RSI of 23, CDXS is in oversold territory.
Over the past 776 weeks of data, CDXS has crossed below its 200-week moving average 7 times. On average, these episodes lasted 59 weeks. Historically, investors who bought CDXS at the start of these episodes saw an average one-year return of +25.3%.
With a market cap of $120 million, CDXS is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -114.3%. The stock trades at 3.1x book value.
Share count has increased 25.7% over three years, indicating dilution.
Over the past 15 years, a hypothetical investment of $100 in CDXS would have grown to $11, compared to $681 for the S&P 500. CDXS has returned -13.7% annualized vs 13.6% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 17 open-market purchases totaling $9,418,926. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while CDXS is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: CDXS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After CDXS Crosses Below the Line?
Across 7 historical episodes, buying CDXS when it crossed below its 200-week moving average produced an average return of +10.4% after 12 months (median -62.0%), compared to +18.3% for the S&P 500 over the same periods. 43% of those episodes were profitable after one year. After 24 months, the average return was -34.6% vs +30.7% for the index.
Each line shows $100 invested at the moment CDXS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
CDXS has crossed below its 200-week MA 7 times with an average 1-year return of +25.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2011 | May 2011 | 3 | 6.0% | -64.2% | -86.1% |
| Jun 2011 | Jan 2015 | 188 | 77.4% | -61.1% | -86.0% |
| Mar 2020 | May 2020 | 11 | 19.3% | +114.5% | -86.4% |
| Jun 2020 | Jul 2020 | 7 | 8.7% | +104.3% | -87.6% |
| Sep 2020 | Oct 2020 | 4 | 5.3% | +135.4% | -88.3% |
| Mar 2022 | Mar 2022 | 1 | 1.7% | -77.3% | -92.7% |
| Apr 2022 | Ongoing | 200+ | 89.1% | Ongoing | -92.8% |
| Average | 59 | — | +25.3% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02